comparemela.com

Latest Breaking News On - Stratec se stock exchange - Page 3 : comparemela.com

STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research gives a Buy rating

Already positive, the research from Warburg Research and its analyst Michael Heider still consider the stock as a Buy opportunity. The target price is unchanged and still at EUR 80. | April 28, 2023

Michael-heider
Warburg-research
Stratec-se-stock-exchange
News
Information
Press-release
Already
The
Research
Rom
Arburg
End

STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2023 AND CONFIRMS FINANCIAL GUIDANCE

EQS-News: STRATEC SE / Key word: Quarter Results/Forecast STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2023 AND CONFIRMS FINANCIAL GUIDANCE 28.04.2023 / 06:55 CET/CEST The issuer. | April 28, 2023

Germany
Frankfurt
Brandenburg
German
German-stock-exchange
Sustainability-corporate-communications
Service-parts
Frankfurt-stock-exchange
Prime-standard
Annual-general-meeting
German-stock

STRATEC BIOMEDICAL SYSTEMS AG : Hauck & Aufhauser reiterates its Buy rating

Analyst Alexander Galitsa from Hauck & Aufhauser research considers the stock attractive and recommends it with a Buy rating. The target price continues to be set at EUR 87. | April 20, 2023

Hauck-aufhauser
Alexander-galitsa
Analyst-alexander-galitsa
Stratec-se-stock-exchange
News
Information
Press-release
Analyst
Alexander
Malitsa
Rom

STRATEC BIOMEDICAL SYSTEMS AG : Berenberg sticks Neutral

Berenberg confirms his opinion on the stock and remains Neutral. The target price is reduced from EUR 77 to EUR 62. | April 14, 2023

Stratec-se-stock-exchange
News
Information
Press-release
Erenberg
Onfirms
Is
Opinion
N
The
Stock

STRATEC BIOMEDICAL SYSTEMS AG : Hauck & Aufhauser reiterates its Buy rating

Analyst Alexander Galitsa from Hauck & Aufhauser research considers the stock attractive and recommends it with a Buy rating. The target price remains unchanged at EUR 87. | April 3, 2023

Hauck-aufhauser
Alexander-galitsa
Analyst-alexander-galitsa
Stratec-se-stock-exchange
News
Information
Press-release
Analyst
Alexander
Malitsa
Rom

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.